Full Text View
Tabular View
No Study Results Posted
Related Studies
Evaluation of Scalp and Hair Shaft With Biologic Markers in African American and Caucasian Hair
This study is ongoing, but not recruiting participants.
Study NCT00690664   Information provided by Wake Forest University
First Received: June 2, 2008   Last Updated: June 10, 2008   History of Changes
This Tabular View shows the required WHO registration data elements as marked by

June 2, 2008
June 10, 2008
April 2007
Observe comparators of African American and Caucasian women's hair [ Time Frame: 3 days ] [ Designated as safety issue: No ]
Same as current
Complete list of historical versions of study NCT00690664 on ClinicalTrials.gov Archive Site
 
 
 
Evaluation of Scalp and Hair Shaft With Biologic Markers in African American and Caucasian Hair
Evaluation of Scalp and Hair Shaft With Biologic Markers in African American and Caucasian Hair

The purpose of this research study is to better understand African American hair and scalp, its biologic appearance and how this relates to African Americans' perceptions of their hair and scalp health. Since most hair studies have looked at Caucasian hair and scalp, we will use a population of Caucasian subjects for comparison in evaluating various hair and scalp parameters.

 
 
Observational
Case Control, Prospective
Scalp Health
 
  • Caucasian women
  • African American women
 

*   Includes publications given by the data provider as well as publications identified by National Clinical Trials Identifier (NCT ID) in Medline.
 
Active, not recruiting
60
September 2008
May 2008   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • Must be willing to sign informed consent
  • Female from the ages of 21-60 years
  • Must be willing to have a thorough scalp and hair shaft examination
  • Must be willing to discuss hair care regimen currently and in the past
  • Must have washed hair at least 48 hours prior to initial study visit
  • Pregnant and nursing females will not be allowed in the study; a baseline pregnancy test will be done to exclude pregnancy on females of childbearing potential
  • Must be >6 months (26 weeks) postpartum
  • Must have sufficient contrast between scalp skin color and hair color
  • Must have hair at least 2 inches long
  • May have mild itching and mild scaling of the scalp
  • Must be willing to have hair clipped and shaved to 1mm within an approximately 2.5cm test site
  • Must be in good stable general health, with no current infections.

Exclusion Criteria:

  • May not have sewn-in or glued hair pieces or extensions at the time of the study
  • Must not cut hair during the study
  • Must not have hair loss beyond what is considered normal in the opinion of the Investigator at the time of the study
  • Must not color hair or have other salon-type procedures (relaxer, permanent, highlighting, etc.) performed within 2 weeks of the initial visit
  • Must not have any other underlying scalp disorder that could interfere with the test procedures or findings
  • Must not have lost ≥10% of body weight within the past 12 months
  • Must not have been on a weight reduction program overseen by a physician or nutritionist within the past 12 months
  • Has used hair growth products e.g. minoxidil in the past 18 months
  • Has undergone a hair transplant or scalp reduction surgery
  • Has participated in a hair growth study within the past 15 months
  • Is currently participating in another clinical study at this or any other facility
  • Is taking, for a chronic condition, any prescription or over the counter medication(s) that in the opinion of the Investigator are likely to affect the hair properties (e.g. immunosuppressive agents, corticosteroids; or chronic use of anti-inflammatory medication)
  • Application of any over-the-counter or prescription drug to the scalp on a routine basis within the past 3 months including but not limited to retinoids (e.g. retinal, tretinoin, retinyl palmitate, retinyl acetate, retinyl propionate), topical corticosteroids, benzyl peroxide, or any topical hormone therapy (e.g. Eterna 27)
Female
21 Years to 60 Years
Yes
 
United States
 
 
NCT00690664
Amy McMichael, MD, Wake Forest University Health Sciences
31716
Wake Forest University
 
Principal Investigator: Amy McMichael, MD Wake Forest University
Wake Forest University
June 2008

 †    Required WHO trial registration data element.
††   WHO trial registration data element that is required only if it exists.